Pancreatitis Clinical Trials

134 recruitingLast updated: July 11, 2026

There are 134 actively recruiting pancreatitis clinical trials across 33 countries. Studies span Not Applicable, Phase 2, Phase 4, Phase 1, Phase 3, Early Phase 1. Top locations include Shanghai, Shanghai Municipality, China, Pittsburgh, Pennsylvania, United States, Baltimore, Maryland, United States. Updated daily from ClinicalTrials.gov.


Pancreatitis Trials at a Glance

134 actively recruiting trials for pancreatitis are listed on ClinicalTrialsFinder across 6 cities in 33 countries. The largest study group is Not Applicable with 40 trials, with the heaviest enrollment activity in Shanghai, Pittsburgh, and Baltimore. Lead sponsors running pancreatitis studies include Changhai Hospital, Mayo Clinic, and Orlando Health, Inc..

Browse pancreatitis trials by phase

Treatments under study

About Pancreatitis Clinical Trials

Looking for clinical trials for Pancreatitis? There are currently 30 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Pancreatitis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Pancreatitis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 134 trials

Recruiting

A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma

Pancreatic CancerPancreatitisPancreatic Cyst+1 more
Memorial Sloan Kettering Cancer Center120 enrolled13 locationsNCT03334708
Recruiting

Organ Dysfunction Change in Acute Necrotizing Pancreatitis Patients With Sepsis After Open Necrosectomy

Necrotizing Pancreatitis
Chunling Jiang200 enrolled1 locationNCT06380842
Recruiting

Registry of Patients Undergoing Endoscopic Management of Pancreatic Fluid Collections

Acute PancreatitisPancreatic PseudocystPancreatic Necrosis
Orlando Health, Inc.110 enrolled1 locationNCT06179459
Recruiting

EUS Procedures Using RIVOS™ EUS Access Device

Chronic PancreatitisPancreatic Cancer Non-resectableBiliary Obstruction+2 more
Orlando Health, Inc.30 enrolled1 locationNCT07696572
Recruiting
Not Applicable

Necrosectomy With Cryotechnology for Accelerated Removal

Acute PancreatitisPancreatic NecrosisAcute Pancreatic Necrosis+3 more
Christopher C. Thompson, MD, MSc20 enrolled1 locationNCT06553651
Recruiting
Not Applicable

Indomethacin vs Diclofenac for Preventing PEP

PancreatitisERCPNon-steroidal Anti-inflammatory (NSAID)+2 more
Air Force Military Medical University, China4,050 enrolled20 locationsNCT07071441
Recruiting
Phase 1Phase 2

Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase

Acute Pancreatitis
St. Jude Children's Research Hospital42 enrolled3 locationsNCT04195347
Recruiting

Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)

Pancreatic CancerChronic PancreatitisDiabetes Mellitus Type 3c
M.D. Anderson Cancer Center775 enrolled10 locationsNCT03460769
Recruiting
Phase 2

A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants With Acute Pancreatitis

Acute Pancreatitis
Panafina, Inc.36 enrolled16 locationsNCT06080789
Recruiting
Phase 2

Phase II Clinical Trial Evaluating the Efficacy and Safety of HRS-7249 and SHR-1918 in Patients With Severe Hypertriglyceridemia at High Risk of Acute Pancreatitis

Severe Hypertriglyceridemia With a High Risk of Acute Pancreatitis
Fujian Shengdi Pharmaceutical Co., Ltd.108 enrolled1 locationNCT07308392
Recruiting

Validation of the Odesa Criteria 2026 for Autoimmune Pancreatitis

Pancreatic CancerChronic PancreatitisIgG4-Related Diseases+1 more
Military Medical Clinical Center of the Southern Region, Ukraine82 enrolled2 locationsNCT07536841
Recruiting
Phase 3

Evaluating the Efficacy of RELiZORB in Managing Exocrine Pancreatic Insufficiency in Tube-fed Pancreatitis Patients

PancreatitisExocrine Pancreatic Insufficiency (EPI)
Massachusetts General Hospital60 enrolled1 locationNCT06691893
Recruiting
Phase 1

STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis

Pancreatic SurgeryChronic PainChronic Pancreatitis+7 more
Indiana University24 enrolled5 locationsNCT05603702
Recruiting
Not Applicable

Cold Water Irrigation Therapy as an Adjunct to Indomethacin for Post-Endoscopic Retrograde Cholangiopancreatography(ERCP) Pancreatitis

PancreatitisERCP Surgery
University of Kansas Medical Center950 enrolled1 locationNCT07330284
Recruiting
Phase 3

Pancreatic Enzyme Replacement in Acute Necrotizing Pancreatitis

Pancreatic exocrine insufficiencyAcute Necrotizing Pancreatitis
Asian Institute of Gastroenterology, India140 enrolled4 locationsNCT07441824
Recruiting
Phase 4

Short-term Intravenous Fluids for Prevention of Post-ERCP Pancreatitis

Post-ERCP Acute Pancreatitis
University of Calgary505 enrolled1 locationNCT06260878
Recruiting
Phase 4

A Study Of Effect Of Secretin For In Injection (Chirostim) On Pancreatic Fluid Composition In Healthy Subjects

Chronic PancreatitisExocrine Pancreatic Insufficiency
Mayo Clinic24 enrolled1 locationNCT07285863
Recruiting
Not Applicable

Clinical Performance of Medical Device Software "Lipidica 1.0" for Processing Data Generated by Lipidomic Analysis in Pancreatic Cancer Screening

Pancreatic Ductal AdenocarcinomaPancreas CancerHereditary Diseases+1 more
Lipidica, a.s.419 enrolled16 locationsNCT06549725
Recruiting
Phase 4

Malabsorption Blood Test (MBT) to Determine Exocrine Pancreatic Function and Related Quality of Life in Chronic Pancreatitis

Chronic PancreatitisExocrine Pancreatic InsufficiencyRecurrent Acute Pancreatitis
Anna Evans Phillips80 enrolled2 locationsNCT07418593
Recruiting
Not Applicable

Pancreatic Cancer Screening in a Population at High Risk

Pancreatic Ductal AdenocarcinomaHereditary DiseasesPancreatitis, Chronic
Masaryk Memorial Cancer Institute700 enrolled1 locationNCT06330441